Relafen 750, containing naproxen sodium, presents a complex case from a biochemical standpoint . Its mechanism of action involves blocking cyclooxygenase (COX) enzymes, specifically COX-2, which results in a reduction of prostaglandin formation. This biochemical process directly impacts inflammation and pain perception, highlighting its role as a p